We found that the NFKB1 −94ins/del ATTG promoter polymorphism was significantly associated with increased risk of cancer; this result was different than a previous meta-analysis [48], which reported that there was no association between the NFKB1 −94ins/del ATTG promoter polymorphism and cancer risk. The gene discussed is NFKB1; the disease is cancer.